Scroll down
Scroll down
However, there are many limitations including: lack of access to emergency procedures, limited scalability, cost, inefficiencies with high risk of cancelled procedures, high CO2 emissions, and more recently COVID.
Not applicable in emergency procedures
Inefficient with high risk of cancelled procedures
Limited scalability
High CO2 emissions
COST €2.000 - €25.000
COVID 19
Benefit/
Product dev. pathway/
Meet the needs
New Product Designed
Shorten the learning curve
Product (FIH) (R&D Support)
Physician Training
Reduce the risks
Clinical Study support
Product Launch
Broaden the product use
Product Maturity
Reduce costs
Anytime proctoring of procedures by a physician or company representatives globally, therefor can optimize / customize support for each procedure.
Continual support for participants in Clinical Studies, thereby reducing risks, standarizing techniques and thereby optimizing results.
Improved access to real-life training opportunities (both physicians and company representatives).
Eliminates logistic barriers, hidden costs, and reduces internal resources required for case support.
Enables scale-up with confidence and control (forcasting symplicity) without capital outlay or mantainance requirements.
Rediuces carbon footprint associated with product support.
Tegus Medical GmbH
Stresemannstrasse 375, Unit 11
22761 Hamburg
